Acceleron Pharma Inc. Pre-Tax Profit Margin 2013-2021 | XLRN
Acceleron Pharma Inc. pre-tax profit margin from 2013 to 2021. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2021-09-30 | $0.11B | $-0.25B | -224.78% |
| 2021-06-30 | $0.10B | $-0.22B | -218.63% |
| 2021-03-31 | $0.11B | $-0.18B | -155.26% |
| 2020-12-31 | $0.09B | $-0.17B | -177.42% |
| 2020-09-30 | $0.11B | $-0.13B | -124.53% |
| 2020-06-30 | $0.09B | $-0.14B | -158.62% |
| 2020-03-31 | $0.08B | $-0.14B | -184.00% |
| 2019-12-31 | $0.07B | $-0.13B | -168.92% |
| 2019-09-30 | $0.04B | $-0.14B | -348.72% |
| 2019-06-30 | $0.04B | $-0.12B | -315.79% |
| 2019-03-31 | $0.01B | $-0.13B | -935.71% |
| 2018-12-31 | $0.01B | $-0.12B | -850.00% |
| 2018-09-30 | $0.01B | $-0.11B | -800.00% |
| 2018-06-30 | $0.01B | $-0.11B | -771.43% |
| 2018-03-31 | $0.01B | $-0.11B | -838.46% |
| 2017-12-31 | $0.01B | $-0.11B | -771.43% |
| 2017-09-30 | $0.01B | $-0.10B | -761.54% |
| 2017-06-30 | $0.01B | $-0.10B | -730.77% |
| 2017-03-31 | $0.01B | $-0.09B | -669.23% |
| 2016-12-31 | $0.03B | $-0.06B | -211.11% |
| 2016-09-30 | $0.03B | $-0.07B | -232.14% |
| 2016-06-30 | $0.03B | $-0.06B | -193.10% |
| 2016-03-31 | $0.03B | $-0.04B | -137.50% |
| 2015-12-31 | $0.02B | $-0.06B | -355.56% |
| 2015-09-30 | $0.02B | $-0.06B | -305.56% |
| 2015-06-30 | $0.02B | $-0.05B | -283.33% |
| 2015-03-31 | $0.02B | $-0.06B | -362.50% |
| 2014-12-31 | $0.02B | $-0.05B | -346.67% |
| 2014-09-30 | $0.02B | $-0.05B | -226.09% |
| 2014-06-30 | $0.02B | $-0.06B | -273.91% |
| 2014-03-31 | $0.05B | $-0.03B | -73.33% |
| 2013-12-31 | $0.06B | $-0.02B | -38.60% |
| 2013-09-30 | $0.05B | $-0.01B | -22.45% |
